An interventional study of Thoracoscopic surgery in Lung Cancer, Lung Cancer Metastatic and Bullous Disease Lung, sponsored by IRB of NTUH Hsin-Chu Branch. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 90 Years. Per ClinicalTrials.gov, last updated 2021-02-25.
Sponsored by IRB of NTUH Hsin-Chu Branch · Not applicable, Interventional, and Treatment
The investigators' study aims is to evaluate the safety and efficacy of uniportal VATS under assistance of needlescopic instruments through additional 2-3 mm ports compared to conventional uniportal VATS in patients with lung lesions.
Lung or mediastinal disease requiring thoracoscopic surgery
Exclusion Criteria:
Thoracoscopic esophagectomy Decortication for empyema
Thoracoscopic surgery performed with the fashion of single 2.5-3.5 cm intercostal incision and 1-2 additional 2-3 mmm needlescopic ports.
Procedure: Thoracoscopic surgery
Conventional uniportal VATS with single 2.5-3.5 cm intercostal incision
Procedure: Thoracoscopic surgery
Video-assisted thoracoscopic surgery for pulmonary or mediastinal lesions.
Pain scale POD 3
Post-operative day 3 pain scale documented using Visual Analogue Scale (VAS)
Time frame: 3 days
Pain scale POD 5
Post-operative day 5 pain scale documented using Visual Analogue Scale (VAS)
Time frame: 5 days
Hospital stay
Post-operative hospital stay
Time frame: 14 days
Post-operative 3 month neuralgia
Out patient documented using PainDETECT questionnaire (PD-Q)
Time frame: 3 months
Post-operative 6 month neuralgia
Out patient documented using PainDETECT questionnaire (PD-Q)
Time frame: 6 months
Cost
Total hospital cost
Time frame: 14 days
Surgical time
Time spend in surgery
Time frame: 1 day
Surgical bleeding
Blood loss during operation
Time frame: 1 day
Opioid using dosage
Total opioid equivalent dose used during post-operative course
Time frame: 14 days
This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
IRB of NTUH Hsin-Chu Branch